DarioHealth Corp. Warrant
DRIOW
DRIOW was delisted on the 4th of March, 2021.
2 hedge funds and large institutions have $23K invested in DarioHealth Corp. Warrant in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
21% more capital invested
Capital invested by funds: $19K → $23K (+$4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WPC
Waters Parkerson & Co
New Orleans,
Louisiana
|
+$5.77K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.22K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $17K | – | – | – |
|
|
WPC
2
Waters Parkerson & Co
New Orleans,
Louisiana
| $5K | +$5.77K | +20,000 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $1K | +$1.22K | +4,229 | +1,057% |
|
DRIOW Hedge Fund Activity: Q3 2017 in Review
2 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q3 2017, worth a combined $23K — up 21% from $19K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new DRIOW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Waters Parkerson & Co, opening a new position worth an estimated $5.77K.
- 2 institutional investors held DarioHealth Corp. Warrant (DRIOW) as of Q3 2017, up from 1 in Q2 2017.
- Funds reported $23K of DarioHealth Corp. Warrant stock for Q3 2017, up 21% quarter-over-quarter.
- 1 fund opened new DarioHealth Corp. Warrant positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest DarioHealth Corp. Warrant buyer in Q3 2017 was Waters Parkerson & Co, an estimated $5.77K added.
Based on aggregated 13F filings for Q3 2017.